Cargando…
Activated p53 in the anti-apoptotic milieu of tuberous sclerosis gene mutation induced diseases leads to cell death if thioredoxin reductase is inhibited
Tuberous sclerosis, angiomyolipoma and lymphangioleiomyomatosis are a group of diseases characterized by mutation in tuberous sclerosis genes (TSC 1-2). TSC mutation leads to continuous activation of the mTOR pathway that requires adaptation to increased ATP requirement. With limited treatment optio...
Autores principales: | Abdelwahab, ElHusseiny M. M., Bovari-Biri, Judit, Smuk, Gabor, Fillinger, Janos, McPhail, Donald, Krymskaya, Vera P., Pongracz, Judit E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8197715/ https://www.ncbi.nlm.nih.gov/pubmed/33860865 http://dx.doi.org/10.1007/s10495-021-01670-4 |
Ejemplares similares
-
Normalization of Enzyme Expression and Activity Regulating Vitamin A Metabolism Increases RAR-Beta Expression and Reduces Cellular Migration and Proliferation in Diseases Caused by Tuberous Sclerosis Gene Mutations
por: Abdelwahab, Elhusseiny Mohamed Mahmoud, et al.
Publicado: (2021) -
Prdx5 in the Regulation of Tuberous Sclerosis Complex Mutation-Induced Signaling Mechanisms
por: Bovari-Biri, Judit, et al.
Publicado: (2023) -
miRNAs as Predictors of Barrier Integrity
por: Bovari-Biri, Judit, et al.
Publicado: (2023) -
KRAS and EGFR Mutations Differentially Alter ABC Drug Transporter Expression in Cisplatin-Resistant Non-Small Cell Lung Cancer
por: Jaromi, Luca, et al.
Publicado: (2021) -
Preparation and Characterization of ACE2 Receptor
Inhibitor-Loaded Chitosan Hydrogels for Nasal Formulation to Reduce
the Risk of COVID-19 Viral Infection
por: Vörös-Horváth, Barbara, et al.
Publicado: (2022)